Purchase Order HT941024P0005
Award Date 11/15/23
Potential Completion Date 11/14/28
Potential Value $94K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lemoore, CA 93245, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $18,752.00 firm fixed price purchase order to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for a four-year extended warranty on the FILM ARRAY equipment at Lemoore Naval Air Station in California. This contract does not have a set-aside designation. Biofire Defense has previously received other prime and subcontract awards from the Department of Defense, Department of...
- The Defense Health Agency awarded a $1.54M firm fixed-price purchase order to Biofire Defense LLC on April 15, 2025, for the procurement of a molecular assay analyzer with an ultimate completion date of April 14, 2026. The equipment will be delivered to Camp Pendleton North, California. Biofire Defense, a Salt Lake City-based manufacturer of molecular diagnostic technologies, specializes in rapid pathogen identification systems and has been an established federal contractor since 2001. This...
- The Defense Health Agency awarded a $288,915 firm fixed-price delivery order to Biofire Defense LLC on October 1, 2025, for BioFire Torch maintenance services at the contractor's San Diego, California facility. This delivery order, subject to availability of funds per Federal Acquisition Regulation clause 52.232-18, is scheduled for completion by September 30, 2030, and was issued under a larger $4.85 million Indefinite Delivery Contract established between the Defense Health Agency and...
- The Defense Health Agency awarded a delivery order to Biofire Defense LLC on October 1, 2025, for an equipment lease contract valued at $968,331.59 through September 30, 2026. The contract covers the lease of two multiplex molecular analyzer systems and the supply of testing panel reagents for the Department of Pathology at Madigan Army Medical Center in Tacoma, Washington. The award employs firm fixed-price pricing and carries no set-aside designation, reflecting Biofire Defense's competitive...
- The Defense Health Agency (DHA) awarded a $3.5 million firm fixed-price purchase order to Biofire Defense LLC on September 30, 2024, for molecular diagnostic kits with a completion date of September 29, 2029. This contract, which includes no set-aside designation, will be performed in Bethesda, Maryland. Biofire Defense is a specialized manufacturer of biological agent identification and molecular diagnostic solutions based in Salt Lake City, Utah, known for its FilmArray and RAZOR Mk II systems...
- The U.S. Bureau of Medical Services awarded a $262,422 firm fixed-price purchase order to BioFire Defense LLC on January 21, 2024, for extended product warranties covering the FilmArray 2.0 polymerase chain reaction (PCR) analyzers. This contract, with an ultimate completion date of January 20, 2027, supports the government's molecular diagnostic capabilities by extending warranty coverage for critical pathogen identification equipment. The award carries no set-aside designation and reflects...
- The U.S. Marine Corps awarded a $16.5K firm fixed-price purchase order to Biofire Defense LLC on March 25, 2026, for BioFire diagnostic panels with an ultimate completion date of April 10, 2026. The award was issued with no set-aside designation to the Salt Lake City-based manufacturer of molecular diagnostic technologies and biological agent identification products. Biofire Defense specializes in rapid pathogen identification systems, leveraging its core product portfolio including FilmArray...
- The Defense Health Agency (DHA) awarded a $5.42 million firm fixed-price purchase order to Biofire Defense LLC for molecular infectious disease polymerase chain reaction (PCR) testing services, effective October 1, 2025, through September 30, 2026, with an ultimate completion date of September 30, 2030. This non-set-aside contract represents DHA's continued investment in advanced diagnostic capabilities for infectious disease detection and biodefense applications. Biofire Defense, a Salt Lake...
- The Bureau of Medicine and Surgery awarded a $18,034 firm fixed-price purchase order to Biofire Defense LLC on December 3, 2024, for the BIOFIRE DEFENSE PRODUCT NGDS-ASY-0017. The contract, which requires completion by February 28, 2025, will be performed in Frederick, Maryland. This purchase order represents a tactical procurement from Biofire Defense, a Salt Lake City-based manufacturer specializing in molecular diagnostic technologies and biological agent identification products. No set-aside...
- The Bureau of Medicine and Surgery awarded a $102,344 firm fixed-price purchase order to Biofire Defense LLC on July 22, 2024, for FilmArray Respiratory Panels 2.1. The contract, which carries no set-aside designation, is scheduled for completion by September 30, 2025, with performance taking place in Peru. Biofire Defense LLC, a Salt Lake City-based limited liability company specializing in molecular diagnostic technologies, has established itself as a key federal vendor for infectious...